PGC associated_with schizophrenia
Evidence from:
primary |
all sources
Evidence (10 sources)
The initial schizophrenia paper has been published by the PGC CNV group.
confidence: 0.90
chief among them is the schizophrenia Nature (19) report which ranks among the most highly cited papers in 2014.
confidence: 0.90
Translating genome-wide association findings into new therapeutics for psychiatry.
(2016)
PMID:27786187
cited
process is beginning for schizophrenia, and the PGC aims to accelerate this
confidence: 0.85
Translating genome-wide association findings into new therapeutics for psychiatry.
(2016)
PMID:27786187
cited
application of human genetics to schizophrenia, led by the PGC ... has identified multiple disease susceptibility loci
confidence: 0.95
Translating genome-wide association findings into new therapeutics for psychiatry.
(2016)
PMID:27786187
cited
this study used PGC2 schizophrenia GWAS data
confidence: 0.90
we included PGC results for schizophrenia (9.5 million markers in 34,241 cases, 45,604 controls, and 1,235 trios ...)
confidence: 0.95
Recent genetic findings in schizophrenia and their therapeutic relevance.
(2015)
PMID:25315827
cited
A new analysis from the PGC on a considerably enlarged sample (‘PGC2’ ... identifying over 100 loci ... genome-wide significant for schizophrenia.
confidence: 0.90
The second evaluation reports the results from the large PGC mega-analysis for schizophrenia
confidence: 0.96
A mega-analysis of genome-wide association studies for major depressive disorder.
(2013)
PMID:22472876
cited
The PGC is conducting GWAS metaanalyses across ADHD, autism, BIP, MDD and schizophrenia.
confidence: 0.90
The results are meant to inform research into schizophrenia.
confidence: 0.90